NCT01476488

Conversion of Prograf to Advagraf in Pediatric Renal Transplant Recipients

Conversion of Twice-a-day Tacrolimus to Once-Daily Tacrolimus Extended-Release Formulation in Stable Pediatric Kidney Transplant Recipients

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: —
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: All
• Age: 5 Years – 15 Years
• Healthy volunteers: Not accepted

Summary

This study was designed to compare the pharmacokinetics of Prograf and Advagraf in stable pediatric kidney transplant recipients. Enrolled patients on prograf will have pharmacokinetic study of tacrolimus for 24 hours and after that, the same dose of advagraf will be prescribed. The patients will have another pharmacokinetic study of tacrolimus after conversion to advagraf.

Conditions

• Kidney Transplantation
• Pediatric Patients
• Maintenance With Tacrolimus

Interventions

Type	Name	Description
DRUG	tacrolimus

Timeline

• Start date: 2011-07-01
• Primary completion: 2013-03-01
• First posted: 2011-11-22
• Last updated: 2015-05-27

Locations

1 site across 1 country: South Korea